InflaRx (IFRX) Dividends Paid - Common (2016 - 2026)
InflaRx (IFRX) posted Dividends Paid - Common of $17.6 million for Q1 2026, up 57.51% sequentially from $11.1 million in Q4 2025, and down 64.71% YoY from $49.7 million in Q1 2025.
InflaRx (IFRX) Dividends Paid - Common (2016 - 2026) Analysis & Trends
InflaRx has reported Dividends Paid - Common for 11 years, with the latest figure at $17.6 million in Q1 2026.
- Quarterly Dividends Paid - Common fell 64.71% year-over-year to $17.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.8 million (down 141.61% YoY) and the FY2025 annual result came in at $18.1 million, down 8.98% from the prior year.
- Dividends Paid - Common climbed to $17.6 million in Q1 2026 per IFRX's latest filing, from $11.1 million in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $49.7 million in Q1 2025 and troughed at -$38.8 million in Q2 2025.
- A 5-year average of $5.0 million and a median of $2.4 million in 2023 frame the typical range for Dividends Paid - Common.
- The sharpest annual moves came in 2024 and 2025: Dividends Paid - Common surged 1111.47% in 2024, then tumbled 505.56% in 2025.
- Over 5 years, Dividends Paid - Common stood at -$1.7 million in 2022, then slumped by 449.73% to -$9.6 million in 2023, then grew by 12.89% to -$8.4 million in 2024, then soared by 233.2% to $11.1 million in 2025, then soared by 57.51% to $17.6 million in 2026.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $17.6 million, $11.1 million, and -$7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 34.60 Mn |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn | 152.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.55 Mn |
| Mar 31, 2026 | 17.55 Mn |
| Dec 31, 2025 | 11.14 Mn |
| Dec 31, 2025 | 11.14 Mn |
| Sep 30, 2025 | -7.66 Mn |
| Sep 30, 2025 | -7.66 Mn |
| Jun 30, 2025 | -38.81 Mn |
| Jun 30, 2025 | -38.81 Mn |
| Mar 31, 2025 | 49.74 Mn |
| Mar 31, 2025 | 49.74 Mn |
| Dec 31, 2024 | -8.37 Mn |
| Dec 31, 2024 | -8.37 Mn |
| Sep 30, 2024 | 7.75 Mn |
| Sep 30, 2024 | 7.75 Mn |
| Jun 30, 2024 | -6.41 Mn |
| Jun 30, 2024 | -6.41 Mn |
| Mar 31, 2024 | 27.27 Mn |
| Mar 31, 2024 | 27.27 Mn |
| Dec 31, 2023 | -9.61 Mn |
| Dec 31, 2023 | -9.61 Mn |